Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference
-
Merus to Present at the Canaccord Genuity 45th Annual Growth Conference
-
Akebia Therapeutics to Present at Canaccord Genuity’s 45th Annual Growth Conference
-
DeFi Technologies' Valour unit reports $947 million in assets under management
-
Orezone completes A$75 million IPO on Australian Securities Exchange
-
Zevra Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
Cybin to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
Orezone Announces Completion of Initial Public Offering on ASX
-
DeFi Technologies Provides Monthly Corporate Update: Valour Reports US$947 Million (C$1.3 Billion) in AUM, and Monthly Net Inflows of US$14.4 Million (C$19.8 Million) in July 2025, Among Other Key Dev
-
Nexxen to Participate in Upcoming Financial Conferences
-
USA Rare Earth to Present at the Canaccord Genuity 45th Annual Growth Conference
-
Vertex (VRTX) PT Lowered to $411 at Canaccord Genuity
-
Neuronetics (STIM) PT Lowered to $7 at Canaccord Genuity
-
Sally Beauty Holdings (SBH) PT Raised to $15 at Canaccord Genuity
-
Hillman Solutions Corp. (HLMN) PT Raised to $15 at Canaccord Genuity
-
Edgewell Personal Care (EPC) PT Lowered to $32 at Canaccord Genuity
-
Canaccord Genuity Downgrades Vivid Seats Inc. (SEAT) to Hold
-
Canaccord Genuity Starts Imricor Medical Systems Inc (IMR:AU) at Buy
-
ReGen III names Brad Kotush as chief financial officer
-
ReGen III Appoints Accomplished Executive as Chief Financial Officer to Drive Next Phase of Growth
-
Travere Therapeutics to Participate at Upcoming Investor Conferences
-
EverQuote to Present at Upcoming Investor Conferences
-
Traeger to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth
-
Rivian is set to report after the bell on Tuesday. Here's what to watch out for.
-
STAAR Surgical (STAA) PT Raised to $28 at Canaccord Genuity
-
Worthington Enterprises Participating in Fireside Chat at Canaccord Genuity Growth Conference
-
CervoMed to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
Alnylam to Webcast Presentation at Canaccord Genuity 45th Annual Growth Conference
-
Lucid Diagnostics to Participate in Upcoming Investor Conferences
-
VSE Corporation Announces August 2025 Investor Conference Schedule
-
Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Palvella Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
Sagimet Biosciences to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference
-
Satellos to Present at Canaccord Genuity’s 45th Annual Growth Conference
-
NTG Clarity to Present at the Canaccord Genuity 45th Annual Growth Conference
-
Olaplex Holdings, Inc. Announces Participation in the Canaccord Genuity 45th Annual Growth Conference on August 12th
-
Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA
-
SI-BONE Inc. (SIBN) PT Raised to $26 at Canaccord Genuity
-
Energizer (ENR) PT Raised to $29 at Canaccord Genuity
-
CVRx Inc (CVRX) PT Lowered to $9 at Canaccord Genuity
-
Ameresco (AMRC) PT Raised to $36 at Canaccord Genuity
-
Aeva Technologies Inc. (AEVA) PT Raised to $24 at Canaccord Genuity
-
Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference
-
Canaccord Genuity Starts Mesoblast Limited (MSB:AU) (MESO) at Buy
-
Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference
-
OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference
-
MP Materials to Participate in Canaccord Genuity’s 45th Annual Growth Conference

